Cargando…
Effect of osteoprotegerin and pamidronate treatment in transgenic mice overexpressing human TNF
Autores principales: | Redlich, K, Maier, A, Hayer, S, Kollias, G, Dunstan, CR, Tohidast-Akrad, M, Lang, S, Woloszczuk, W, Steiner, G, Smolen, JS, Schett, G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273175/ http://dx.doi.org/10.1186/ar263 |
Ejemplares similares
-
Therapeutic targeting of osteoclasts by osteoprotegerin and bisphosphonates leads to a reduction of TNFalpha-mediated bone resorption
por: Redlich, K, et al.
Publicado: (2001) -
Adenoviral-based overexpression of TIMP-1 reduces tissue damage in the joints TNF-transgenic mice
por: Schett, G, et al.
Publicado: (2001) -
Adenoviral-based overexpression of TIMP-1 reduces tissue damage in the joints of TNF-alpha transgenic mice
por: Schett, G, et al.
Publicado: (2001) -
Osteoprotegerin protects from generalized bone loss in TNF-transgenic mice
por: Hayer, S, et al.
Publicado: (2003) -
Osteoclasts are essential for TNF-mediated joint destruction
por: Redlich, KR, et al.
Publicado: (2002)